Photo: Business Standard

Corbevax Vaccine Approved As Booster Dose For Adults: Union Health Ministry

After Covaxin and Covishield, the Union Health Ministry also approved Corbevax as a booster dose against Covid-19.  Biological E's Corbevax is allowed for double-vaccinated people above 18-years-old. The recommendations were given by the National Technical Advisory Group on Immunisation (NTAG). Corbevax, considered a precaution dose will be given six months or 26 weeks from the date of the second dose of either Covaxin/Covisheild. Necessary… read-more

Wed, 10 Aug 2022 - 12:33 PM / by Varsha Joshi

Tags: Covid-19, Booster Dose, Union Health Ministry, Covaxin, COVISHIELD

Courtesy: NDTV


Photo: NDTV

Covaxin Safe For Children Aged 2-18, Finishes Clinical Trials: BBIL

Bharat Biotech International Limited (BBIL) announced that after phase II/III trials, Covaxin can safely be administered to children between ages two and 18. Reportedly, the phases II/III studies were conducted to evaluate the safety, reactogenicity and immunogenicity of the vaccine in healthy children and adolescents. "We have now achieved our goal of developing safe and efficacious Covid-19 vaccine for adults and children," said Dr Krishna… read-more

Fri, 17 Jun 2022 - 07:18 PM / by Shibu Immanuel S

Tags: Covaxin, BBIL, Covid-19, Covid Vaccine, children vaccine

Courtesy: ANI

Corbevax, India’s First Heterologous Booster Vaccine For Covid

Photo: Times Now

Corbevax, India’s First Heterologous Booster Vaccine For Covid, Approved By DCGI

The Covid-19 vaccine Corbevax, manufactured by BiologicalE in Hyderabad, is the first to be licensed as a heterologous booster in adults by Drugs Controller General of India. Individuals who had Covishield/Covaxin for their first two doses can get Corbevax as their third. Following the booster dosage of Corbevax, neutralizing antibodies against Omicron variation were identified in 91% of individuals who had received Covishield and in 75% who… read-more

Sat, 04 Jun 2022 - 08:15 PM / by Vidhi Jhunjhunwala

Tags: Covid-19, Coronavirus Vaccines, Covaxin, COVISHIELD, Corbevax, Drugs Controller General of India

Courtesy: The Indian Express

DCGI Approves vaccine for children

Photo: The Times Of India

DCGI Approves Covaxin For Children Between 6-12 Year Old, Corbevax For EUA

The Drugs Controller General of India (DCGI) approved the two vaccines Covaxin and Corbevax for children under 12 in India, against COVID-19. While Bharat Biotech's Covaxin has been approved for 6 to12-year-old, Biological E's Corbevax will be used as Emergency Use Authorization (EUA) for 5 to12-year-old kids in India. The approval was based on the Subject Expert Committee's recommendation report, which was prepared as per trials of the… read-more

Tue, 26 Apr 2022 - 04:23 PM / by Varsha Joshi

Tags: Covaxin, covid-19 vaccines, DCGI, Corbevax, children

(Representational Image)

Photo: Science Business

Haryana Govt Rolls Out "Free" Boosters For 18-59 Age Group

The Haryana government has rolled out "free" booster doses for the 18-59 age group. The announcement came just days after the Delhi government made booster shots freely available for the age group. Around a whopping Rs 300 crores of taxpayers' money out of the state Covid-19 Relief Fund would be dedicated to this program. Experts are divided on the need for these "precautionary" doses.

Tue, 26 Apr 2022 - 03:30 PM / by Varun Das

Tags: Covid-19, Coronavirus, Covid Vaccine, COVISHIELD, Covaxin

Courtesy: Zee News

Covishield and Covaxin

Photo: The Times of India

PGI Chandigarh To Study Covid-19 Vaccine Mixing

The PGI Chandigarh has got the approval of the drug regulator of India to study the mixing of Covid-19 vaccines. The study would help conclude what happens when a person who is fully vaccinated with either Covishield or Covaxin would respond to getting the booster dose of the other vaccine. The purpose of the study is also to compare homologous vaccination to heterologous vaccination.

Sun, 17 Apr 2022 - 12:01 PM / by Varun Das

Tags: Covid-19, Coronavirus Vaccines, Covid-19 Vaccine, Covishield vaccine, Covaxin

Courtesy: The Economic Times


Photo: Zee News

WHO Suspends UN Supply Of COVID-19 Vaccine 'Covaxin'

The WHO suspended the supply of Covaxin, an India-made (Bharat Biotech) Covid-19 vaccine through UN agencies. The decision was taken to allow the manufacturer to upgrade facilities and address deficiencies found in an inspection. In a statement, the organization pointed out that the company needs facility upgrade, "For the coming period the company will focus on pending facility maintenance, process, and facility optimization activities," … read-more

Sun, 03 Apr 2022 - 04:05 PM / by Devadutta Deb

Tags: Covid-19, Covaxin, Vaccination, WHO, United Nations

Courtesy: NDTV

Bharat Biotech

Photo: Twitter

Bharat Biotech Slow Downs Covaxin Production, Releases Statement

Hyderabad-based Bharat Biotech, manufactures of India-made Covaxin, announced to slow down production temporarily. On April 1, the pharma company said, "For the coming period, the company will focus on pending facility maintenance, process, and facility optimisation activities". The decision came after recent WHO post Emergency Use Listing inspection, which emphasized on need of optimization activities. The companies also ensured to be… read-more

Sat, 02 Apr 2022 - 01:15 PM / by Varsha Joshi

Tags: Bharat biotech, Covaxin, Production, WHO, Hyderabad


Photo: DCGI website

DCGI Grants Market Approval To Covishield & Covaxin With Conditions

The Drugs Controller General of India (DCGI) on January 27, granted regular market approval to India's Covaxin and Covishield vaccines against COVID-19. Following SEC's recommendations, the DCGI allowed only hospitals and clinics to purchase the SII's Covishield and Bharat Biotech's Covaxin under the New Drugs And Clinical Trials 2019 Act. However, the authority needs to submit data every six months to the DCGI and update on CoWIN app.

Thu, 27 Jan 2022 - 07:13 PM / by Varsha Joshi

Tags: COVISHIELD, Covaxin, Drugs Controller General of India, INDIAN MARKET, covid-19 vaccines

Courtesy: News 18

COVID-19 vaccines

Photo: Hindustan Times

India-Made COVID-19 Vaccines Likely To Get Market Approval With Capped Prices

The two COVID-19 vaccines, Covishield and Covaxin will soon get the regular market approval with capped prices. According to the Drug Controller General of India, the SII and Bharat Biotech urged the DGCI to grant regular market approval for adult population with certain conditions. If approved, vaccines will be available at Rs 275 plus Rs 150 additional charges. Notably, Covaxin and Covishield are available at Rs 1,200 and 780, respectively… read-more

Wed, 26 Jan 2022 - 08:08 PM / by Varsha Joshi

Tags: Covaxin, Covishield vaccine, Bharat biotech, Serum Institute of India, DRUG CONTROLLER GENERAL OF INDIA

Courtesy: Zee News